BioSpace News Archive

Bio-One® has named prominent franchise industry leader Danessa Itaya as the company’s new president.

Novartis Pharmaceuticals Canada Inc. is pleased to announce the official opening of its new Montréal office in the heart of Old Montréal.

Evogene Ltd. today announced its financial results for the first quarter period ending March 31, 2023.

Standard BioTools Inc. today announced the launch of NGS library preparation functionality on the X9™ High-Throughput Genomics System.

FibroGen, Inc. today announced positive topline data from Company’s Phase 3 clinical study of roxadustat for treatment of anemia in patients receiving concurrent chemotherapy treatment for non-myeloid malignancies in China.

BridGene Biosciences, Inc. announced that Wolf Wiedemeyer , Ph.D., head of biology at BridGene, will be giving a presentation, titled “A Covalent TEAD Inhibitor with Exceptional Anti-cancer Activity & Combination Potential,” at the 2nd Annual Hippo Pathway Targeted Drug Development Summit on May 24 in Boston.

Affinia Therapeutics today announced the presentation of new preclinical data on novel AAV capsids for skeletal muscle, cardiac muscle, and central nervous system (CNS).

Replay, a genome writing company reprogramming biology by writing and delivering big DNA, announced the appointment of Arun Balakumaran, M.D., Ph.D., as Chief Medical Officer, effective 22 May.

VYNE Therapeutics Inc. announced that members of management will attend the Biotechnology Innovation Organization International Convention, taking place June 5-8, 2023 at the Boston Convention & Exhibition Center in Boston, Massachusetts.

InspireMD, Inc. announced that, in connection with the appointment of Shane Gleason as General Manager of North America and VP of Global Marketing in February 2023, InspireMD granted Mr. Gleason 256,450 shares of restricted stock and stock options to purchase 85,480 shares of InspireMD’s common stock.